Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01321437
Title Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, Irvine
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.